Profil
Marc Le Bozec was the founder of BioProtein Technologies SA, founded in 1998, holding the title of Chairman & Chief Executive Officer.
Current jobs include Chief Executive Officer at CYTOO SA since 2013, Chairman at La Financière du Faouet SASU, Treasurer & Director at France Biotech Association since 2014, Director at Clevexel Pharma SAS, Director at TransCure BioServices SASU since 2019, Director at Keranova SA, Director at Scipio Bioscience SAS, Director at NG Biotech SAS, Director at NH TherAguix SAS since 2019, Director at Mexbrain SAS, and Director at Monatomics Technology SAS. Former jobs include Director at Takara Bio Europe AB, Chief Financial Officer & IR Contact at Cellectis SA from 2006 to 2013, and Fund Manager at Financière Arbevel SA. Education includes an undergraduate degree from École des Hautes Études Commerciales de Paris.
Aktiva positioner av Marc Le Bozec
| Företag | Position | Start |
|---|---|---|
| NH THERAGUIX SAS | Direktör/Styrelseledamot | 2019-02-22 |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays | Verkställande Direktör | 2025-01-01 |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Direktör/Styrelseledamot | 2014-06-12 |
Mexbrain SAS
Mexbrain SAS Medical SpecialtiesHealth Technology Manufactures therapeutic dialysis devices for metal extraction | Direktör/Styrelseledamot | - |
Clevexel Pharma SAS
Clevexel Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Direktör/Styrelseledamot | - |
Transcure Bioservices SAS
Transcure Bioservices SAS Packaged SoftwareTechnology Services Develops humanized software platform | Direktör/Styrelseledamot | 2019-01-01 |
NG Biotech SAS
NG Biotech SAS Medical SpecialtiesHealth Technology Develops and manufactures in vitro diagnostic tools | Direktör/Styrelseledamot | - |
Scipio Bioscience SAS
Scipio Bioscience SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Direktör/Styrelseledamot | - |
Keranova SA
Keranova SA Medical SpecialtiesHealth Technology Designs and develops surgical equipment for ophthalmologic | Direktör/Styrelseledamot | - |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
Tidigare kända positioner av Marc Le Bozec
| Företag | Position | Slut |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░ ░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░░░░ | - |
Marc Le Bozecs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 16 |
|---|---|
Financière Arbevel SA
Financière Arbevel SA Investment ManagersFinance ARBEVEL is an active, long-term manager which focuses on the French small and mid-cap segment. The firm follows a pragmatic and opportunistic approach to investments in growth companies which they consider undervalued by the market or companies undergoing restructuring. They also seek to identify the companies best positioned to benefit from major structural trends including technological breakthroughs, biotechnology stakes, security, aging of the population, in order to accompany them in their development. ARBEVEL performs bottom-up, fundamental and strategic analysis of companies, including business analysis, the competitive environment, financial situation, management and valuation of the company. | Finance |
Cellectis SA
Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
BioProtein Technologies SA
BioProtein Technologies SA BiotechnologyHealth Technology Develops recombinant therapeutic proteins and vaccines | Health Technology |
École des Hautes Études Commerciales de Paris
École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
France Biotech Association
France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry | Commercial Services |
Takara Bio Europe AB
Takara Bio Europe AB Miscellaneous Commercial ServicesCommercial Services Develops hepatocytes and cardiomyocytes from the proprietary stem cells | Commercial Services |
CYTOO SA
CYTOO SA Medical SpecialtiesHealth Technology Operates as a contract research organization which develops physiological cell-based assays | Health Technology |
Clevexel Pharma SAS
Clevexel Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Transcure Bioservices SAS
Transcure Bioservices SAS Packaged SoftwareTechnology Services Develops humanized software platform | Technology Services |
Keranova SA
Keranova SA Medical SpecialtiesHealth Technology Designs and develops surgical equipment for ophthalmologic | Health Technology |
Scipio Bioscience SAS
Scipio Bioscience SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
NG Biotech SAS
NG Biotech SAS Medical SpecialtiesHealth Technology Develops and manufactures in vitro diagnostic tools | Health Technology |
NH TherAguix SAS
NH TherAguix SAS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops nanomedicine for cancer, combining imaging and radiotherapy | Health Technology |
Mexbrain SAS
Mexbrain SAS Medical SpecialtiesHealth Technology Manufactures therapeutic dialysis devices for metal extraction | Health Technology |
Monatomics Technology SAS | |
La Financière du Faouet SASU |
















